Rosuvastatin Tablet, Film Coated
Product Images NDC 71610-797

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71610-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0797 45)

This is the product label information for Rosuvastatin, USP. It includes package details such as the manufacturer's address and the batch number. The GTIN (Global Trade Item Number) is provided along with batch and expiration information.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure-01 (Figure 1)

The text is not clearly readable. Therefore, a description cannot be generated.*

FDA Label Image

Figure-02 (Figure 2)

This is a statistical summary of a clinical trial comparing the effects of Rosuvastatin 20 mg versus a placebo on various endpoints in a group of 8,901 participants. The results show a significant reduction in the primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, and hospitalizations due to unstable angina and arterial revascularization with Rosuvastatin compared to placebo. The hazard ratios and confidence intervals for each endpoint are provided, suggesting a clear benefit of Rosuvastatin in reducing cardiovascular events.*

FDA Label Image

Figure-02 (Figure 3)

FDA Label Image

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.